Literature DB >> 20962055

Clinicopathological evaluation of 100 cases of mucinous carcinoma of breast with emphasis on axillary staging and special reference to a micropapillary pattern.

Aditi Ranade1, Rashmi Batra, Gagangeet Sandhu, Rohit A Chitale, Jasminka Balderacchi.   

Abstract

BACKGROUND: Pure mucinous breast carcinoma (PMBC) is uncommon and associated with better prognosis than mixed mucinous breast carcinoma (MMBC). A micropapillary pattern in PMBC has been identified although its prognostic significance is questionable.
METHODS: A retrospective review of 100 cases of mucinous carcinoma diagnosed between 2000 and 2009 was conducted. Two broad categories were studied: PMBC (more than 90% mucinous component; n=45) and MMBC (less than 90% mucinous component; n=55). PMBC was further subclassified as hypocellular/type A (n=37) and cellular/type B (n=8). Receptor status, clinicomorphological and prognostic features were compared without patient follow-up.
RESULTS: Mean age at diagnosis in PMBC and MMBC was 60 and 63 years, while mean tumour size was 1.65 and 2.5 cm, respectively. Mean age in type A and type B PMBC patients was 75 and 55 years, respectively. The majority of PMBCs were well differentiated, with two poorly differentiated cases as well. The majority of MMBCs were moderately differentiated. A micropapillary pattern was seen in 20% of PMBCs. Sentinel lymph nodes were positive in 18.5% of PMBCs and 16% of MMBCs. Non-sentinel lymph nodes were positive in 14% of PMBCs and 39% of MMBCs. A micropapillary pattern was seen in 60% of LN positive PMBCs and 14% of LN negative PMBCs. Furthermore, 95% of PMBCs were ER(+), 84% were PR(+) and 9% were Her-2(+); 91% of MMBCs were ER(+), 87% were PR(+) and 33% were Her-2(+).
CONCLUSIONS: PMBCs with a micropapillary pattern were more frequently associated with nodal disease. PMBCs with axillary disease had one or more of the following: micropapillary pattern, high nuclear grade, Her-2 positivity, smaller tumour size or younger age. Hence, axillary staging by sentinel lymph node biopsy is recommended in PMBCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962055     DOI: 10.1136/jcp.2010.082495

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  Expression of vascular endothelial growth factor and caspase-3 in mucinous breast carcinoma and infiltrating ductal carcinoma-not otherwise specified, and the correlation with disease-free survival.

Authors:  Qiuli Wang; Lisha Sun; Jici Yan; Shuo Wang; Juncheng Zhang; Xinyu Zheng
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

2.  Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinoma.

Authors:  Fresia Pareja; Pier Selenica; David N Brown; Ana P M Sebastiao; Edaise M da Silva; Arnaud Da Cruz Paula; Angela Del; Li Fu; Britta Weigelt; Edi Brogi; Jorge S Reis-Filho; Hannah Y Wen
Journal:  Histopathology       Date:  2019-06-13       Impact factor: 5.087

3.  Mucinous carcinoma with micropapillary features is morphologically, clinically and genetically distinct from pure mucinous carcinoma of breast.

Authors:  Peng Sun; Zaixuan Zhong; Qianyi Lu; Mei Li; Xue Chao; Dan Chen; Wenyan Hu; Rongzhen Luo; Jiehua He
Journal:  Mod Pathol       Date:  2020-05-01       Impact factor: 7.842

4.  Mucinous Breast Cancer: a Review Study of 5 Year Experience from a Hospital-Based Series of Cases.

Authors:  Adrian Dumitru; Alexandru Procop; Andreea Iliesiu; Mircea Tampa; Luminita Mitrache; Mariana Costache; Maria Sajin; Anca Lazaroiu; Monica Cirstoiu
Journal:  Maedica (Buchar)       Date:  2015-03

5.  Invasive mucinous carcinoma of the breast.

Authors:  Kelli Y Ha; Patricia Deleon; William Deleon
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-07

6.  The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.

Authors:  Xingtong Zhou; Zhibo Zheng; Yan Li; Weiwei Zhao; Yan Lin; Jieshi Zhang; Qiang Sun
Journal:  BMC Cancer       Date:  2021-05-11       Impact factor: 4.430

7.  Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma.

Authors:  Shinichiro Kashiwagi; Naoyoshi Onoda; Yuka Asano; Satoru Noda; Hidemi Kawajiri; Tsutomu Takashima; Masahiko Ohsawa; Seiichi Kitagawa; Kosei Hirakawa
Journal:  Springerplus       Date:  2013-09-23

8.  Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.

Authors:  Lei Lei; Xingfei Yu; Bo Chen; Zhanhong Chen; Xiaojia Wang
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

9.  Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women.

Authors:  Hsin-Shun Tseng; Che Lin; Szu-Erh Chan; Su-Yu Chien; Shou-Jen Kuo; Shou-Tung Chen; Tsai-Wang Chang; Dar-Ren Chen
Journal:  World J Surg Oncol       Date:  2013-06-14       Impact factor: 2.754

10.  Triple-Positive Breast Carcinoma: Histopathologic Features and Response to Neoadjuvant Chemotherapy.

Authors:  Jennifer Zeng; Marcia Edelweiss; Dara S Ross; Bin Xu; Tracy-Ann Moo; Edi Brogi; Timothy M D'Alfonso
Journal:  Arch Pathol Lab Med       Date:  2021-06-01       Impact factor: 5.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.